El trading conlleva riesgos
Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
El trading conlleva riesgos
Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
Español (Latinoamérica)
ResMed Inc
Cerrado
SectorSalud
230.97 -0.8
Resumen
Variación precio
24h
Mínimo
230
Máximo
232.49
Ingresos | 44M 393M |
|---|---|
Ventas | 87M 1.4B |
P/B Media del Sector | 24.993 61.417 |
Rentabilidad por dividendo | 0.89 |
Margen de beneficio | 27.593 |
Empleados | 10,600 |
EBITDA | 63M 566M |
Recomendaciones | Comprar |
|---|---|
Estimación a 12 meses | +27.45% upside |
Rentabilidad por dividendo Media del Sector | 0.89% 2.40% |
|---|---|
Próximas Ganancias | 22 abr 2026 |
Fecha Próximo Dividendo | 19 mar 2026 |
Próxima Fecha de Ex Dividendo | 7 may 2026 |
Capitalización de Mercado | -371M 37B |
|---|---|
Apertura anterior | 231.77 |
Cierre anterior | 230.97 |
Noticias sobre sentimiento de mercado
By Acuity
28%
72%
65 / 351 Clasificación en Healthcare
ResMed Inc Gráfico
El rendimiento pasado no es un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
ResMed Inc Esperado
Precio Objetivo
By TipRanks
27.45% repunte
Estimación a 12 meses
Media 296.2 USD 27.45%
Máximo 345 USD
Mínimo 265 USD
De acuerdo con 12 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para ResMed Inc Dist en los últimos 3 meses.
Sentimiento
By Acuity
65 / 351 Clasificación en Salud
Noticias sobre sentimiento de mercado
Coyuntura alcista
Volatilidad
Por debajo de la media
Volumen de Noticias (RCV)
Por encima de la media
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de ResMed Inc
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Live chat